World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
26572
World Ranking
8946
National Ranking
3972

Overview

Gerald E. Marti is affiliated with the National Institutes of Health in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a significant focus on subfields including Genetics, Immunology, Molecular Biology, Pathology and Forensic Medicine, and Oncology.

The main topics of Gerald E. Marti's work include Chronic Lymphocytic Leukemia Research, Immunodeficiency and Autoimmune Disorders, Lymphoma Diagnosis and Treatment, Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Cancer Research and Treatments, and Monoclonal and Polyclonal Antibodies Research.

Gerald E. Marti's recent publications cover a range of subjects within hematology and immunology. Significant papers include:

  • Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines (2020, Blood)
  • EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma (2024, Blood)
  • Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families (2020, Blood)
  • Towards an FDA-cleared basophil activation test (2023, Frontiers in Allergy)
  • Serum microRNA profiles among dioxin exposed veterans with monoclonal gammopathy of undetermined significance (2020, Journal of Toxicology and Environmental Health)

Marti frequently publishes in journals such as Blood, Leukemia & Lymphoma, Cancer Research, Frontiers in Allergy, and Frontiers in Genetics. The majority of their work appears in Blood, with at least five publications in that venue alone.

Collaborative efforts are a notable aspect of Marti's research. Frequent co-authors include Adrian Wiestner, Clare Sun, Maryalice Stetler-Stevenson, Neil E. Caporaso, and Ru Wen, each having contributed to multiple joint publications.

Best Publications

  • Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

    Ash A. Alizadeh;Michael B. Eisen;R. Eric Davis;Izidore S. Lossos

  • ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

    Adrian Wiestner;Andreas Rosenwald;Todd S. Barry;George Wright

  • The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

    Yair Herishanu;Patricia Pérez-Galán;Delong Liu;Angélique Biancotto

  • Diagnostic criteria for monoclonal B-cell lymphocytosis.

    Gerald E. Marti;Andy C. Rawstron;Paolo Ghia;Peter Hillmen

  • Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.

    Mohammed Z H Farooqui;Janet Valdez;Sabrina Martyr;Georg Aue

  • B-cell clones as early markers for chronic lymphocytic leukemia.

    Ola Landgren;Maher Albitar;Wanlong Ma;Fatima Abbasi

  • Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice

    Elizabeth S. Raveche;Erica Salerno;Brian J. Scaglione;Vijaya Manohar

  • Human peripheral blood B-cell compartments: A crossroad in B-cell traffic†

    M Perez-Andres;B Paiva;W G Nieto;A Caraux

  • The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes.

    A. Alizadeh;A. Alizadeh;M. Eisen;R. E. Davis;C. Ma

  • Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells.

    J W Gratama;A Orfao;D Barnett;B Brando

  • Hematotoxocity among Chinese workers heavily exposed to benzene

    Nathaniel Rothman;Gui-Lin Li;Mustafa Dosemeci;William E. Bechtold

  • Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib

    Clare Sun;Xin Tian;Yuh Shan Lee;Sreenivasulu Gunti

  • Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study

    Sarah E. M. Herman;Carsten U. Niemann;Mohammed Farooqui;Jade Jones

  • Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study

    Inhye E. Ahn;Mohammed Z. H. Farooqui;Xin Tian;Janet Valdez

  • Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study

    Carsten U. Niemann;Sarah E.M. Herman;Irina Maric;Julio Gomez-Rodriguez

  • Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32

    Lucia Conde;Eran Halperin;Nicholas K. Akers;Kevin M. Brown

  • Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib

    Andrew H. Lipsky;Mohammed Z.H. Farooqui;Xin Tian;Sabrina Martyr

  • B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia.

    Gerald E. Marti;Patricia Carter;Fatima Abbasi;Glennelle C. Washington

  • Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response

    Andreas Rosenwald;Eric Y. Chuang;R. Eric Davis;Adrian Wiestner

  • U.S.‐Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures

    Gregory T. Stelzer;Gerald Marti;Anne Hurley;Phil McCoy

Frequent Co-Authors

Neil E. Caporaso
Neil E. Caporaso National Institutes of Health
Maryalice Stetler-Stevenson
Maryalice Stetler-Stevenson National Institutes of Health
Wyndham H. Wilson
Wyndham H. Wilson National Institutes of Health
Lynn R. Goldin
Lynn R. Goldin National Institutes of Health
Neil E. Kay
Neil E. Kay Mayo Clinic
Diane C. Arthur
Diane C. Arthur National Institutes of Health
Thomas A. Fleisher
Thomas A. Fleisher National Institutes of Health
Susan L. Slager
Susan L. Slager Mayo Clinic
Ola Landgren
Ola Landgren University of Miami
J. Brice Weinberg
J. Brice Weinberg Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens many doors to in-demand careers in healthcare, nutrition, and diagnostic imaging. If you want to apply your scientific knowledge in practical settings, consider related online degrees that offer flexibility and clear job prospects.

Healthcare professionals with backgrounds in biology can advance their expertise with options like a cheapest online nutrition degree, helping you make evidence-based recommendations for community wellness. Those interested in medical diagnostics may pursue online sonography programs to become sonographers, working closely with physicians to assist in patient care.

For a quicker entry into the healthcare field, 1 year radiology tech programs online provide training for radiologic technologist positions. If you wish to specialize further, dietetics masters programs prepare you to become a registered dietitian or nutrition expert.

Online programs make it easier to balance your studies with work or family, offering pathways that blend scientific understanding with practical career skills.

Best Scientists Citing Gerald E. Marti

Trending Scientists

Recently Published Articles